| Literature DB >> 31602222 |
Wei Huang1, Wei Gan1, An Huang2, Yulei Fu3, Yuzhi Shang3, Yue Chen3, Zhao Tian4, Yun Zhang5, Gang Fang5.
Abstract
Efficacy of electroacupuncture combined with probiotics for depression and chronic diarrhea in patients, and its effect on the levels of serum inflammatory cytokines, norepinephrine (NE) and brain-derived neurotrophic factor (BDNF) were investigated. A total of 104 patients with depression and chronic diarrhea admitted to The First Clinical Faculty, Guangxi University of Traditional Chinese Medicine from July 2014 to June 2018 were randomly divided into the observation group (n=56) and the control group (n=48). The observation group was treated with electroacupuncture combined with probiotics, and the control group was given conventional drugs for depression and chronic diarrhea. The Hamilton Depression Rating Scale (HAM-D) score and the abdominal symptom score were evaluated before treatment and at 3 weeks after treatment. Changes in the levels of serum inflammatory cytokines [interleukin (IL)-6, IL-2 and tumor necrosis factor (TNF)-α] as well as the levels of NE and BDNF in the two groups of patients before and after treatment were determined using radioimmunoassay. Compared with those in the control group, the symptoms of depression and diarrhea in the observation group were remarkably alleviated (p<0.05). After treatment, the serum cytokine levels in the two groups of patients were decreased, and the decreased level of serum inflammatory cytokines in the observation group was not obviously different from that in the control group. Besides, the serum BDNF level in the observation group was also reduced (p<0.05). The overall efficacy of the observation group was superior to that of the control group, showing a statistical difference. Electroacupuncture combined with probiotics brings good efficacy to patients with depression and chronic diarrhea, which is worthy of clinical promotion and development. Copyright: © Huang et al.Entities:
Keywords: brain-derived neurotrophic factor; chronic diarrhea; cytokine; depression; electroacupuncture; norepinephrine; probiotics
Year: 2019 PMID: 31602222 PMCID: PMC6777321 DOI: 10.3892/etm.2019.7977
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447
Comparison of the HAM-D score between the two groups of patients (mean ± SD).
| Observation group (n=56) | Control group (n=48) | |||
|---|---|---|---|---|
| Items | Before treatment | After treatment | Before treatment | After treatment |
| Total score of HAM-D | 32.34±5.43 | 15.57±3.79 | 29.34±6.09 | 14.34±4.65 |
| Weight | 2.47±1.08 | 0.89±0.47 | 1.97±2.16 | 1.03±0.66 |
| Sleep disorder | 5.42±2.13 | 1.45±1.34 | 5.86±3.18 | 2.95±2.13[ |
| Anxiety/somatization | 6.36±4.24 | 4.21±1.93 | 5.96±4.67 | 3.84±1.82 |
| Day and night change | 1.72±0.86 | 0.85±0.47 | 1.57±0.67 | 0.99±0.83 |
| Retardant | 7.48±3.54 | 4.16±2.35 | 6.95±2.64 | 4.67±3.12 |
| Feeling of despair | 5.36±2.37 | 3.58±1.83 | 4.97±1.86 | 3.74±2.11 |
| Cognitive disorder | 6.84±3.83 | 3.68±2.85 | 7.46±2.93 | 5.17±2.04[ |
P<0.05 vs. control group after treatment. HAM-D, Hamilton Depression Rating Scale; SD, standard deviation.
Comparison of the intestinal flora between the two groups of patients (Ig CFU/g, mean ± SD).
| Observation group (n=56) | Control group (n=48) | |||
|---|---|---|---|---|
| Intestinal flora | Before treatment | After treatment | Before treatment | After treatment |
| Enterobacterium | 13.94±2.83 | 7.54±2.36 | 14.25±3.04 | 8.13±3.62 |
| 10.68±2.37 | 7.31±3.17 | 11.53±3.64 | 9.64±3.58 | |
| 10.78±6.35 | 10.39±3.22 | 11.23±7.26 | 11.02±3.15[ | |
| 6.67±1.36 | 9.63±1.37 | 6.96±1.21 | 9.52±3.04 | |
| 9.62±0.95 | 10.04±1.05 | 8.43±1.03 | 9.56±1.85 | |
P<0.05 vs. control group after treatment. SD, standard deviation.
Figure 1.Comparison of the (A) serum inflammatory cytokines and (B) serum TNF-α after treatment between the two groups of patients. TNF-α, tumor necrosis factor-α; IL, interleukin.
Comparison of the levels of NE and 5-HT before and after treatment between the two groups of patients.
| Observation group (n=56) | Control group (n=48) | |||
|---|---|---|---|---|
| Items | Before treatment | After treatment | Before treatment | After treatment |
| NE (ng/ml) | 0.86±0.57 | 0.59±0.23[ | 0.92±0.63 | 0.67±0.31 |
| 5-HT (ng/ml) | 79.58±43.54 | 154.38±59.62[ | 82.43±39.84 | 138.56±61.37 |
P<0.05 vs. control group after treatment. NE, norepinephrine; 5-HT, 5-hydroxytryptamine.
Figure 2.Comparison of the BDNF levels before and after treatment in the two groups of patients. *P<0.05, compared to that before treatment. BDNF, brain-derived neurotrophic factor.
Comparison of the efficacy of chronic diarrhea between the two groups of patients [n (%)].
| Groups | Markedly effective | Effective | Ineffective | Total effective rate |
|---|---|---|---|---|
| Observation (n=56) | 32 | 21 | 3 | 94.64%[ |
| Control (n=48) | 23 | 18 | 7 | 85.42% |
P<0.05 vs. control group after treatment.